IQVIA Holdings | IQV - Umsatzkosten

Aktienkurs
166.78
Täglich Wechseln
-6.40 -3.70%
Monatlich
-5.07%
Jährlich
21.48%
Q2 Prognose
165.72




Umsatzkosten Veränderung Datum
Accenture USD 12.58B 39.7M 2025-12
Agilent USD 852M 19M 2025-12
Bruker USD 443.6M 84.4M 2026-03
Cardinal Health USD 58.54B 4.82B 2026-03
Celltrion KRW 107.42B 295.44B 2025-12
Charles River Laboratories USD 716.51M 5.76M 2026-03
Cigna USD 62.41B 4.1B 2026-03
Cognizant Technology Solutions USD 3.78B 105M 2026-03
Computer Programs Systems USD 52.17M 9.8M 2025-12
Cspc Pharmaceutical CNY 2.11B 173.58M 2025-12
CVS Health USD 84.8B 7.32B 2026-03
Danaher USD 2.36B 512M 2026-03
Dentsply International USD 453M 65M 2026-03
Deva Holding AS TRY 991.13M 182.81M 2023-09
Divis Laboratories Ltd INR 10.63B 1.23B 2025-12
Elevance Health USD 38.07B 75M 2025-12
Humana USD 26.54B 1.15B 2025-03
IBM USD 7.76B 787M 2025-12
Illumina USD 370M 30M 2026-03
Infosys INR 326.17B 322.65B 2025-12
Kangmei Pharma CNY 1.11B 84.66M 2025-09
Knight Therapeutics CAD 82.22M 1.03M 2025-12
Laboratorios Farma EUR 186.09M 11.06M 2023-12
Laboratory Of America USD 2.6B 4.2M 2026-03
McKesson USD 92.25B 10.22B 2026-03
Mettler Toledo International USD 410.92M 63.05M 2026-03
Organigram Holdings CAD 56.93M 20.53M 2025-12
Pharma Mar EUR 3.66M 116K 2026-03
Qiagen NV USD 217.43M 29.65M 2025-12
Quest Diagnostics USD 1.99B 57M 2026-03
Revvity USD 323.46M 26.93M 2026-03
Sartorius EUR 484.6M 46.6M 2026-03
Sino Biopharmaceutical CNY 3.08B 589.65M 2025-06
Thermo Fisher Scientific USD 6.96B 620M 2026-03
Tilray USD 164.37M 8.41M 2025-09
UnitedHealth USD 94.72B 2.2B 2025-12
Veeva Systems USD 213.48M 14.01M 2025-12
Veradigm USD 124.74M 56.25M 2022-12
Waters USD 725M 350.06M 2026-03
Zealand Pharma A/S 410K 5K 2025-06
Zz Pientze Pharmaceu CNY 1.58B 245.15M 2026-03